11 Hot Healthcare Stocks To Buy Now

Published on December 27, 2023 at 7:35 pm by Fatima Farooq in Hedge Funds, News

In this article, we will be taking a look at 11 hot healthcare stocks to buy now. To skip our detailed analysis of the healthcare sector, you can go directly to see the 5 Hot Healthcare Stocks To Buy Now.

Healthcare is a vital part of daily living for everyone, whether it be to cure an illness or to ensure that you stay healthy through prompt checkups and consistent care for yourself. As a result, healthcare companies are among those that remain ever popular among investors and consumers alike because they are the type to never go out of fashion since we will always need medical care. However, in today’s tech-dominated market, many investors may be concerned about the prospects for other sectors, including healthcare, and their performance through the end of the year and into 2024.

“We Could Really Use Some Strength in the Downtrodden Healthcare Sector”

On November 30, CNBC’s Jim Cramer discussed his opinions on the healthcare sector on ‘Mad Money,’ most notably about what is holding the healthcare sector back and how one can navigate a tech-dominated market. Here are some of his comments:

“First, we are talking about a whole sector that’s in the crosshairs of the US government because we’re headed into an election year. The entire election may actually hinge on the cost of things going too high, even as it is going lower according to all indicators. Of course, if you’re going lower from a much higher base than pre-pandemic, and lower inflation simply means that price are rising more slowly, they’re not falling, it won’t cut it. And that make’s healthcare a natural whipping boy for the government.”

So, according to Cramer, one factor holding back the healthcare sector today is the involvement of the government in the sector in preparation for the upcoming elections in the US. A CNBC article from December 7 highlighted how President Biden’s administration had seized the patents of several costly medications to ramp up its efforts to slash drug prices and promote competition in the pharmaceutical industry as well. Biden has also been working on making lower drug prices a pillar of his healthcare agenda and reelection strategy. Such a move thus serves as a good example of the government involvement in the healthcare sector noted by Cramer. An implication of such a move by the Biden administration can be the slowdown in the healthcare sector.

Another trend Cramer noted that somewhat explains the healthcare sector slowdown is the fact that many people today are continuing to hold back when it comes to going for non-urgent surgeries. Here’s what Cramer had to say on this and how that impacts medical device companies in the healthcare sector:

“Finally, the medical device business… crushed during COVID when people decided to hold of on all sorts of non-urgent surgeries. The strangest thing is, they’re still holding off. The numbers never come back. Very hard to figure. Whatever the case, the healthcare group seems a pretty unlikely candidate to help the bullish cause.”

Healthcare and Tech

Despite the above, the fact that technology today is continuing to evolve and expand its horizons means that other sectors, like healthcare, will also benefit instead of just being overshadowed by a massive tech rally in the market. On November 30, Robert Garrett, the CEO of Hackensack Meridian Health, joined CNBC to discuss the impact of artificial intelligence (AI), in particular, on the healthcare sector. Here’s what he had to say:

“I see AI as the most profound technology in the world today. If you think about it from a healthcare perspective, whether it’s helping doctors diagnose disease earlier, helping more people enroll in clinical trials, there’s no question that AI can improve healthcare in remarkable ways.”

In light of the above, despite the current slowdown in the healthcare sector, investors can treat this as a moment to consider some hot healthcare stocks to buy now as plausible additions to their portfolios since tech like AI is bound to rapidly improve healthcare companies and their products. The present slowdown can be seen as an opportunity to buy stocks like Eli Lilly and Company (NYSE:LLY), UnitedHealth Group Inc. (NYSE:UNH), and Johnson & Johnson (NYSE:JNJ) before they blow up after incorporating advanced technology in their operations and products. Considering this, we have compiled a list of some hot healthcare stocks to buy now. These include some of the best long-term healthcare stocks and cheap healthcare stocks as well.

A healthcare professional preparing a vial for a patient in need of biotechnology services.

Our Methodology

We used a stock screen to find healthcare stocks with a 3-month average volume of over five million and ranked the stocks on this basis from the lowest to the highest volume to show the level of demand for these stocks as of December 27. We have also used Insider Monkey’s hedge fund data for the third quarter to show the number of hedge funds holding stakes in them.

Hot Healthcare Stocks To Buy Now

11. Tempest Therapeutics, Inc. (NASDAQ:TPST)

Average 3-month Volume as of December 27: 11.4 million

Number of Hedge Fund Holders: 6

Tempest Therapeutics, Inc. (NASDAQ:TPST) is a clinical-stage oncology company that develops small molecule therapeutics combining tumor-targeted and immune-mediated mechanisms to treat tumors. The company is based in Brisbane, California.

Joseph Pantginis at HC Wainwright & Co. maintained a Buy rating and a $47 price target on shares of Tempest Therapeutics, Inc. (NASDAQ:TPST) on October 11.

Six hedge funds were long Tempest Therapeutics, Inc. (NASDAQ:TPST) in the third quarter, with a total stake value of approximately $592,500.

10. C4 Therapeutics, Inc. (NASDAQ:CCCC)

Average 3-month Volume as of December 27: 12.1 million

Number of Hedge Fund Holders: 14

Soleus Capital was the largest shareholder in C4 Therapeutics, Inc. (NASDAQ:CCCC) at the end of the third quarter, holding 2.7 million shares in the company.

C4 Therapeutics, Inc. (NASDAQ:CCCC) is a biotechnology company based in Watertown, Massachusetts. The company develops therapeutic candidates to degrade disease-causing proteins to treat cancer, neurodegenerative conditions, and other diseases.

As of December 13, Bradley Canino at Stifel holds a Buy rating and a $12 price target on shares of C4 Therapeutics, Inc. (NASDAQ:CCCC).

There were 14 hedge funds long C4 Therapeutics, Inc. (NASDAQ:CCCC) in the third quarter. Their total stake value in the company was $19.8 million.

Like Eli Lilly and Company (NYSE:LLY), UnitedHealth Group Inc. (NYSE:UNH), and Johnson & Johnson (NYSE:JNJ), C4 Therapeutics, Inc. (NASDAQ:CCCC) is a hot healthcare stock to buy now.

9. Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Average 3-month Volume as of December 27: 12.78 million

Number of Hedge Fund Holders: 31

On December 22, Daniela Bretthauer at HSBC initiated coverage on shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) with a Hold rating and a $27 price target.

Based in Deerfield, Illinois, Walgreens Boots Alliance, Inc. (NASDAQ:WBA) is a drug retail company that operates in the US, the United Kingdom, Germany, and internationally. It operates through three segments: US Retail Pharmacy, International, and US Healthcare.

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) was spotted in the 13F holdings of 31 hedge funds at the end of the third quarter, with a total stake value of $459 million.

Marshall Wace LLP was the most prominent shareholder in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) at the end of the third quarter, holding 5.4 million shares in the company.

8. Bristol-Myers Squibb Company (NYSE:BMY)

Average 3-month Volume as of December 27: 14.2 million

Number of Hedge Fund Holders: 65

Two Sigma Advisors was the most prominent shareholder in Bristol-Myers Squibb Company (NYSE:BMY) at the end of the third quarter, holding 6.6 million shares in the company.

A Buy rating and a $68 price target were maintained on shares of Bristol-Myers Squibb Company (NYSE:BMY) on December 27 by Geoff Meacham at Bank of America Securities.

Bristol-Myers Squibb Company (NYSE:BMY) is a pharmaceutical company based in New York. It discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products across the globe.

We saw 65 hedge funds long Bristol-Myers Squibb Company (NYSE:BMY) in the third quarter. Their total stake value in the company was $1.9 billion.

7. Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO)

Average 3-month Volume as of December 27: 14.45 million

Number of Hedge Fund Holders: 4

Four hedge funds were long Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) in the third quarter, with a total stake value of approximately $51,900.

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) is a biotechnology company based in Chicago, Illinois. It uses artificial intelligence-powered precisions to develop cardiovascular medicines, among more.

6. Tilray, Inc. (NASDAQ:TLRY)

Average 3-month Volume as of December 27: 15.45 million

Number of Hedge Fund Holders: 17

Tilray, Inc. (NASDAQ:TLRY) is a pharmaceutical company based in Leamington, Ontario, in Canada. The company researches, cultivates, processes, and distributes medical cannabis products internationally.

In total, 17 hedge funds were long Tilray, Inc. (NASDAQ:TLRY) in the third quarter. Their total stake value in the company was $84.2 million.

Like Eli Lilly and Company (NYSE:LLY) and UnitedHealth Group Inc. (NYSE:UNH), Tilray, Inc. (NASDAQ:TLRY) is among the hottest healthcare stocks to buy now.

Click to continue reading and see the 5 Hot Healthcare Stocks To Buy Now.

AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Published on December 13, 2024 at by Inan Dogan, PhD

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

The whispers are turning into roars.

Artificial intelligence isn’t science fiction anymore.

It’s the revolution reshaping every industry on the planet.

From driverless cars to medical breakthroughs, AI is on the cusp of a global explosion, and savvy investors stand to reap the rewards.

Here’s why this is the prime moment to jump on the AI bandwagon:

Exponential Growth on the Horizon: Forget linear growth – AI is poised for a hockey stick trajectory.

Imagine every sector, from healthcare to finance, infused with superhuman intelligence.

We’re talking disease prediction, hyper-personalized marketing, and automated logistics that streamline everything.

This isn’t a maybe – it’s an inevitability.

Early investors will be the ones positioned to ride the wave of this technological tsunami.

Ground Floor Opportunity: Remember the early days of the internet?

Those who saw the potential of tech giants back then are sitting pretty today.

AI is at a similar inflection point.

We’re not talking about established players – we’re talking about nimble startups with groundbreaking ideas and the potential to become the next Google or Amazon.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 10,000% Return: This AI Stock is a Diamond in the Rough (But Our Help is Key!)

The AI revolution is upon us, and savvy investors stand to make a fortune.

But with so many choices, how do you find the hidden gem – the company poised for explosive growth?

That’s where our expertise comes in.

We’ve got the answer, but there’s a twist…

Imagine an AI company so groundbreaking, so far ahead of the curve, that even if its stock price quadrupled today, it would still be considered ridiculously cheap.

That’s the potential you’re looking at. This isn’t just about a decent return – we’re talking about a 10,000% gain over the next decade!

Our research team has identified a hidden gem – an AI company with cutting-edge technology, massive potential, and a current stock price that screams opportunity.

This company boasts the most advanced technology in the AI sector, putting them leagues ahead of competitors.

It’s like having a race car on a go-kart track.

They have a strong possibility of cornering entire markets, becoming the undisputed leader in their field.

Here’s the catch (it’s a good one): To uncover this sleeping giant, you’ll need our exclusive intel.

We want to make sure none of our valued readers miss out on this groundbreaking opportunity!

That’s why we’re slashing the price of our Premium Readership Newsletter by a whopping 70%.

For a ridiculously low price of just $29, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single restaurant meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• 30-Day Money-Back Guarantee: If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $29.

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Subscribe Now!

No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a year later!

China’s terrifying internet “Master Key”… and the one microcap that could stop them

Published on December 18, 2024 at by Insider Monkey Staff

In August 2024, news outlets around the world revealed one of the most shocking data breaches in recent history.

Approximately 2.9 billion records, including names, email addresses, phone numbers, mailing addresses, financial data and, distressingly, Social Security numbers, were stolen when Coral Springs, Florida, firm National Public Data (NPD) suffered a massive cyberattack. The company confirmed that the breach, which happened in December 2023, resulted in the potential leaks of data in the summer of 2024.

Nearly every day in the news, we hear about yet another damaging data breach or ransomware attack that puts valuable data — including yours — into the hands of hackers. And the number of attacks is soaring — up 30% year over year according to the latest numbers.

As bad as this is, it’s a day at the beach compared to what’s coming.

That’s because hostile nations across the globe — including Iran, North Korea, Russia and Communist China are going all-out to develop a breakthrough technology that will unlock what I call the “Master Key” to the Internet.

If they succeed in harnessing this groundbreaking “Master Key” technology, the consequences could be catastrophic.

Click to continue reading…

Insider Monkey Ads

Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Log In

Sign Up